123 related articles for article (PubMed ID: 18778946)
1. Treatment planning for a synchrotron-based radiotherapy modality.
Manolopoulos S; Wojnecki C; Green S; Hugtenburg RP; Jones B
Appl Radiat Isot; 2009 Mar; 67(3):492-4. PubMed ID: 18778946
[TBL] [Abstract][Full Text] [Related]
2. Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.
Rivard MJ; Zamenhof RG
Appl Radiat Isot; 2004 Nov; 61(5):753-7. PubMed ID: 15308139
[TBL] [Abstract][Full Text] [Related]
3. Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy.
Rousseau J; Boudou C; Estève F; Elleaume H
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):943-51. PubMed ID: 17544004
[TBL] [Abstract][Full Text] [Related]
4. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy.
Jung SH; Yoon SM; Park SH; Choi IS; Kim JK; Choi EK; Ahn SD; Lee SW; Song SY; Kim JH
Appl Radiat Isot; 2009; 67(7-8):1180-4. PubMed ID: 19321353
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
6. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of dose calculations with SERA and JCDS treatment planning systems.
Koivunoro H; Kumada H; Seppälä T; Kotiluoto P; Auterinen I; Kankaanranta L; Savolainen S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S126-9. PubMed ID: 19406653
[TBL] [Abstract][Full Text] [Related]
8. Verification of the accuracy of BNCT treatment planning system THORplan.
Li HS; Liu YW; Lee CY; Lin TY; Hsu FY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S122-5. PubMed ID: 19386507
[TBL] [Abstract][Full Text] [Related]
9. Prediction of boron concentrations in blood from patients on boron neutron capture therapy.
Shibata Y; Matsumura A; Yamamoto T; Akutsu H; Yasuda S; Nakai K; Nose T; Yamamoto K; Kumada H; Hori N; Ohtake S
Anticancer Res; 2003; 23(6D):5231-5. PubMed ID: 14981995
[TBL] [Abstract][Full Text] [Related]
10. Assessment of dose rate scaling factors used in NCTPlan treatment planning code for the BNCT beam of THOR.
Hsu FY; Liu MT; Tung CJ; Hsueh Liu YW; Chang CC; Liu HM; Chou FI
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S130-3. PubMed ID: 19375926
[TBL] [Abstract][Full Text] [Related]
11. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.
Adam JF; Joubert A; Biston MC; Charvet AM; Peoc'h M; Le Bas JF; Balosso J; Estève F; Elleaume H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):603-11. PubMed ID: 16338098
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
[TBL] [Abstract][Full Text] [Related]
13. Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.
Adam JF; Biston MC; Rousseau J; Boudou C; Charvet AM; Balosso J; Estève F; Elleaume H
Phys Med; 2008 Jun; 24(2):92-7. PubMed ID: 18407772
[TBL] [Abstract][Full Text] [Related]
14. Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
Suzuki M; Tanaka H; Sakurai Y; Kashino G; Yong L; Masunaga S; Kinashi Y; Mitsumoto T; Yajima S; Tsutsui H; Sato T; Maruhashi A; Ono K
Radiother Oncol; 2009 Jul; 92(1):89-95. PubMed ID: 19329206
[TBL] [Abstract][Full Text] [Related]
15. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
[TBL] [Abstract][Full Text] [Related]
16. Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements.
Boudou C; Troprès I; Rousseau J; Lamalle L; Adam JF; Estève F; Elleaume H
Phys Med Biol; 2007 Aug; 52(16):4881-92. PubMed ID: 17671341
[TBL] [Abstract][Full Text] [Related]
17. Normalisation of prescribed dose in BNCT.
Binns PJ; Riley KJ; Harling OK; Albritton JR; Kiger WS
Radiat Prot Dosimetry; 2007; 126(1-4):610-4. PubMed ID: 17522033
[TBL] [Abstract][Full Text] [Related]
18. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
19. Development of a new multi-modal Monte-Carlo radiotherapy planning system.
Kumada H; Nakamura T; Komeda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S118-21. PubMed ID: 19394839
[TBL] [Abstract][Full Text] [Related]
20. Radiochromic film dosimetry of contrast-enhanced radiotherapy (CERT).
Morris KN; Weil MD; Malzbender R
Phys Med Biol; 2006 Nov; 51(22):5915-25. PubMed ID: 17068373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
